Comprehensive molecular characterization of gastric cancer patients from phase II second-line ramucirumab plus paclitaxel therapy trial.
Seung Tae KimJason K SaSung Yong OhKyung KimJung Yong HongWon Ki KangKyoung-Mee KimJeeyun LeePublished in: Genome medicine (2021)
The study was registered on ClinicalTrial.gov ( NCT02628951 ) on June 12, 2015.